Hall is responsible for leading research initiatives across the university, overseeing research advancement, administration and ethics activities. Hall’s experience includes serving as the founder/principal investigator for two national research centers, the Center for Risk and Economic Analysis of Terrorism Events (CREATE), and the National Center for Metropolitan Transportation Research (METRANS). He also served as senior associate dean for research in the Viterbi School of Engineering for four years. Hall was chair of Industrial and Systems Engineering during a period when the faculty size grew by 50%, and when it became the first named academic department at the University of Southern California, upon receipt of a $10 million gift from Daniel J. Epstein.
Hall is the author of Queueing Methods for Services and Manufacturing (Prentice Hall, 1997) and the editor of Handbook of Transportation Science (Springer, 2003), Patient Flow, Reducing Delay in Healthcare Delivery (Springer, 2006) and Handbook of Healthcare System Scheduling (Springer, 2012). He has been funded by the National Science Foundation, U.S. Departments of Homeland Security and Transportation, California Department of Transportation, Los Angeles County Department of Health Services and L.A. Care. Dr. Hall has numerous publications in the areas of transportation, logistics, system engineering, and queueing. Hall received his Ph.D. (1982) and M.S. (1980) in civil engineering from U.C. Berkeley. He received his B.S. in industrial engineering and operations research from U.C. Berkeley in 1979.
Jennifer Dyer is the Executive Director of the USC Stevens Center for Innovation
As Executive Director, she leads a team of 30 to ensure that USC supports translational research, intellectual property management, patenting, licensing, startups, mentoring and translational funding.
Dyer has 20 years of experience and a strong record of success in technology transfer, including serving as Director of Technology Development at The Scripps Research Institute. At TSRI, Dyer contributed to growth in both licensing activity and corporate sponsored research, including the management of major funding relationships with Novartis, Johnson & Johnson and PPG. Her experience at TSRI includes supervising 800 licensing negotiations for equity, royalties and other financial terms, formation of 30 start-up companies and more than 300 research funding agreements.
Dyer joins USC from Life Technologies Corporation, where she served as a Corporate Development Consultant, leading the development of negotiation strategy and negotiating key licensing deals. Prior to Life Technologies, Dyer served as Vice President of Business Development for Wellspring Worldwide where she developed the strategy for the marketing and sales of Wellspring’s Knowledge Management System to corporations and academic institutions, as well as expansion into Asia-Pacific markets.
Dyer is a Certified Licensing Professional and has a degree in Physiology from California State University, Long Beach. Dyer has been an active member of the Association of University Technology Managers (AUTM) and the Licensing Executives Society (LES) since 1993.
Steven Moldin is the Executive Director of the USC Washington, DC Office of Research Advancement
Moldin directs USC’s research advancement efforts in Washington, D.C. He has conducted research at New York State Psychiatric Institute/Columbia University and was a faculty member at Washington University School of Medicine. In 1995, Moldin joined the National Institute of Mental Health (NIMH), one of the National Institutes of Health, to manage an extramural research portfolio. He left in 2006, having led the Office of Human Genetics & Genomic Resources and having served as Associate Director of the Division of Neuroscience and Basic Behavioral Science. Moldin was responsible for the fiscal and scientific management of a $200 million grants and contracts portfolio, and increased the yearly funding of NIMH’s human genetics research portfolio by 56% over two years.
Moldin is an associate editor of Genes, Brain, and Behavior and serves on the editorial board of the American Journal of Medical Genetics. Moldin has published over 50 papers and book chapters in the areas of psychiatric genetics, schizophrenia, autism and neuroscience. He is co-editor of Methods in Genomic Neuroscience and Understanding Autism: From Basic Neuroscience to Treatment.
Moldin received his B.A. magna cum laude with distinction and Phi Beta Kappa in psychology from Boston University (1983), his M.A. in psychology from Yeshiva University (1985), and his Ph.D. in clinical psychology from Yeshiva University (1988). He completed an internship at Hillside Hospital – Long Island Jewish Medical Center (1988) and received postdoctoral training in genetics at Washington University School of Medicine (1988-1991).
Jeri L. Muniz
Jeri Muniz is the Executive Director of the Department of Contracts and Grants
Jeri began working in the field of research administration as a student at the University of California, Irvine. After graduating with a B.A. in Psychology, she began her career in the Department of Microbiology and Molecular Genetics, but soon found her way back to research administration. During her fourteen year tenure at UCI, Jeri assumed a number of roles in research administration: Grants Officer, Contracts Officer, Trainer, Conflict of Interest Administrator, Assistant Director and Director, Sponsored Projects. Jeri joined the Trojan Family as the Executive Director for the Department of Contracts and Grants in March, 2008. As Executive Director, she is responsible for the overall management and administration of pre- and post-award non-financial services related to extramural proposals and awards.
Jeri is also an active member of the National Council of University Research Administrators (NCURA) and is currently Chair-Elect for Region VI. Jeri is frequent presenter on such topics as subrecipient monitoring, working with industry, and strategies for successful negotiations.
Susan Rose is the Executive Director of the Office for the Protection of Research Subjects
Dr. Susan L. Rose serves as the Executive Director in the Office for the Protection of Research Subjects at the University of Southern California. She was hired to achieve AAHRPP accreditation for USC, which entailed developing a unified Human Subjects Protection Program for both campuses, developing policies, establishing best practices, and fostering research ethics education. The accreditation goal was met in 2007 and since then, efforts are directed to making the program continuously better and addressing researcher and regulatory needs.
Formerly, Dr. Rose was the Human Subjects Program Manager at the U.S. Department of Energy, a program she created in the early 1980’s. Her emphasis there included extensive education and communication, a philosophy Dr. Rose has nurtured at USC. She has produced for DOE, and currently for USC, widely disseminated publications, newsletters, and booklets. She is very active in national human subjects policy and educational forums. Dr. Rose taught biology before she entered government service and is currently an Adjunct Professor in the USC School of Pharmacy.
Dr. Rose serves or has served on several international and national human subjects research groups including: the CITI (online Human Subjects Education) developers group, the faculty of PRIM&R (Public Responsibility in Medicine & Research); the planning committee and a speaker for the annual AAHRPP (national accrediting body) conference, and maintains membership in the US Dept of Energy Human Subjects working group. Dr. Rose is currently a member of an advisory group to OHRP, the federal office in HHS that oversees human subjects protections.
Donald Casebolt is the Director of the Department of Animal Resources
Dr. Don Casebolt received his B.S. in Animal Science, Masters in Preventive Veterinary Medicine, and Doctor of Veterinary Medicine degrees from the University of California, Davis. He completed a National Institutes of Health fellowship in laboratory animal medicine and comparative medicine at the University of Alabama at Birmingham. He is board certified by the American College of Laboratory Animal Medicine.
Casebolt has research interests and publications in the fields of comparative virology, molecular-based diagnostic tests for viral diseases, preventive medicine of laboratory animal populations, and animal research facility design. He has served as a consultant to the Association for Assessment and Accreditation of Laboratory Animal Care, International and to the Canadian Council on Animal Care. He serves on the editorial boards of the Journal of the American Association for Laboratory Animal Science and Comparative Medicine and is a member of the Board of Directors of the California Society for Biomedical Research.
Silvia da Costa
Silvia da Costa is the Director of Faculty Research Relations
Dr. Silvia da Costa is responsible for leading all of our internal and institutionally limited competitions. She serves as our interface to the faculty on all matters related to customer services and will also develop and evaluate metrics of research performance for the university and the office.
Previously, Silvia was Research Project Manager in the Department of Diabetes and Metabolic Diseases Research at City of Hope, where she authored and edited scientific content and coordinated major proposals. She also worked in industry as a research scientist at Access Business Group, investigating the efficacy and safety of medicinal plants for use in therapeutic product development. She holds various product patents.
As a business owner in the scientific field she authored SBIR-equivalent European grants for small businesses in technical, IT, engineering and medical research and edited and wrote grants and journal manuscripts in diverse disciplines. She also managed multidisciplinary research teams, secured strategic alliances with private sector entities, universities, government agencies and cooperatives for multi-country partnership grant requirements. Her background includes living and working overseas in Spain, Italy and Brazil. Silvia is a native speaker of both English and Portuguese and has working knowledge of Spanish, French and Italian.
Silvia holds Doctoral and Master’s degrees in Pharmaceutical Sciences from the University of Southern California. Her research focused on cytoskeletal filament system regulation of membrane traffic in lacrimal gland acini, as well as the development of an experimental disease model for Sjogren’s syndrome. She holds Bachelor’s degrees in Physics, Journalism and French from California State University.